Dual Lax Extra Strong Coated Tablets

Țară: Malta

Limbă: engleză

Sursă: Medicines Authority

Cumpara asta acum

Prospect Prospect (PIL)
21-05-2024

Ingredient activ:

CASCARA, ALOIN, SENNA LEAF

Disponibil de la:

G. R. Lane Health Products Limited Sisson Road, Gloucester, GL2 0GR, United Kingdom

Codul ATC:

A06AB

INN (nume internaţional):

CASCARA 130 mg ALOIN 10 mg SENNA LEAF 32 mg

Forma farmaceutică:

COATED TABLET

Compoziție:

CASCARA 130 mg ALOIN 10 mg SENNA LEAF 32 mg

Tip de prescriptie medicala:

OTC

Zonă Terapeutică:

DRUGS FOR CONSTIPATION

Statutul autorizaţiei:

Withdrawn

Data de autorizare:

2005-12-23

Prospect

                                6. FURTHER INFORMATION
What Dual-Lax Extra Strong Tablets contain
The active substances per tablet are:
Senna Leaf (_Cassia senna_ L. folium)......................32mg
Extract (as dry extract) from Cascara bark
(_Rhamnus purshianus_ D.C.),
Extraction solvent: water ......................................130mg
Aloin
......................................................................................10mg
The other ingredients are:
Core: Calcium Phosphate, Magnesium Stearate, 
Pregelatinised Maize Starch, Silicon Dioxide, Sodium 
Starch Glycolate, Stearic Acid.
Coating: Acacia, Calcium Carbonate, Carnauba Wax, Ethyl 
Acetate, Hydrochloric Acid, Iron Oxide, Polyvinyl Acetate 
Phthalate, Sodium Propyl Parahydroxybenzoate (E217), 
Sodium Methyl Parahydroxybenzoate (E219), Sucrose, 
Stearic Acid, Talc, Titanium  Dioxide, Yellow  Beeswax.
What Dual-Lax Extra Strong Tablets look like and
contents of the pack
Dual-Lax Extra Strong Tablets are brown, circular,
coated tablets. They are available in bottles containing
100 tablets.
Marketing Authorisation Holder and Manufacturer
G. R. Lane Health Products Limited,
Sisson Road,
Gloucester,
GL2 0GR,
United Kingdom.
Tel: +44 (0)1452 524012
Email: duallax@laneshealth.com
This leaflet was last approved November 2009  533036
D
UAL-
L
AX
EXTRA STRONG
TABLETS
READ ALL OF THIS LEAFLET CAREFULLY BECAUSE IT
CONTAINS IMPORTANT INFORMATION FOR YOU.
This medicine is available without prescription.
However, you still need to take Dual-Lax Extra Strong
Tablets carefully to get the best results from them.
• Keep this leaflet. You may need to read it again.
•   Ask your pharmacist if you need more information 
or advice.
•  You must contact a doctor if your symptoms worsen 
or do not improve after 7 days. 
•  If any of the side effects become serious, or if you 
notice any side effect not listed in this leaflet, please  
tell your doctor or pharmacist.
In this leaflet:
1.  What Dual-Lax Extra Strong Tablets are and what
                                
                                Citiți documentul complet
                                
                            

Caracteristicilor produsului

                                Page 1 of 8 
SUMMARY OF PRODUCT CHARACTERISTICS 
 
1 
NAME OF THE MEDICINAL PRODUCT 
 
Dual Lax Extra Strong Coated Tablets 
 
2 
QUALITATIVE AND QUANTITATIVE COMPOSITION 
 
Ingredients 
mg/tablet 
Senna leaf (_Cassia senna _L. folium) 
32 
Aloin 
10 
Extract (as dry extract) from Cascara bark 
(_Rhamnus purshianus _D.C. (_Frangula purshiana _
(D.C.) A Gray ex J.C. Cooper), 
Extraction solvent: water 
130 
 
Excipients:  Sucrose  (92mg/tablet),  sodium  propyl  parahydroxybenzoate  E217  and  sodium 
methyl parahydroxybenzoate E219. 
 
For a full list of excipients, see section 6.1. 
 
3 
PHARMACEUTICAL FORM 
 
Coated tablet. 
Brown circular biconvex sugar coated tablet. 
 
4 
CLINICAL PARTICULARS 
 
4.1 
THERAPEUTIC INDICATIONS 
 
For the relief of temporary constipation. 
 
4.2 
POSOLOGY AND METHOD OF ADMINISTRATION 
 
For oral use. 
Adults and children aged 12 and over: Swallow 1 or 2 tablets with water at night. 
Not recommended for children under 12 years old. 
 
4.3 
CONTRAINDICATIONS 
 
Children under 12 years old. 
Hypersensitivity to the active substances or to any of the excipients. 
 
Page 2 of 8 
Cases of intestinal obstructions and stenosis, atony, appendicitis, inflammatory colon 
diseases (e.g. Crohn’s disease, ulcerative colitis), abdominal pain of unknown origin, severe 
dehydration state with water and electrolyte depletion.  
Patients  with  rare  hereditary  problems  of  fructose  intolerance,  glucose-galactose 
malabsorption or sucrase-isomaltase insufficiency should not take this medicine. 
 
4.4 
SPECIAL WARNINGS AND PRECAUTIONS FOR USE 
 
This  product  contains  sodium  propyl  parahydroxybenzoate  (E217)  and  sodium  methyl 
parahydroxybenzoate  (E219)  and  should  not  be  used  by  patients  who  are
                                
                                Citiți documentul complet